Skip to main content
. 2024 Sep 24;13(32):2401187. doi: 10.1002/adhm.202401187

Table 1.

Results of injection tests on both commercially available and under development therapeutic formulations. For each gel, 3 chips were used (n = 9 injections). 1Molar mass calculated by asymmetrical flow field‐flow fractionation (AF4) analysis; 2Altman et al. Cartilage (2016).

Substance name Average molecular weight [kDa] Success rate
SYN321 6111 100%
NaHA 6671 89%
Supartz® 9002 100%